Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.40 CAD
Change Today 0.00 / 0.00%
Volume 0.0
SQD On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 1:52 PM 08/21/15 All times are local (Market data is delayed by at least 15 minutes).

sqi diagnostics inc (SQD) Snapshot

Open
C$0.40
Previous Close
C$0.40
Day High
C$0.40
Day Low
C$0.40
52 Week High
01/5/15 - C$0.71
52 Week Low
12/15/14 - C$0.27
Market Cap
24.7M
Average Volume 10 Days
2.5K
EPS TTM
C$-0.11
Shares Outstanding
61.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SQI DIAGNOSTICS INC (SQD)

Related News

No related news articles were found.

sqi diagnostics inc (SQD) Related Businessweek News

No Related Businessweek News Found

sqi diagnostics inc (SQD) Details

SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company’s proprietary microarray tests and automated instruments are designed to simplify antigen, protein, and antibody testing workflow. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite bench-top system that offers laboratories with workflow solutions from dilutions through reporting to run protein and antibody multiplexed immunoassays; and sqid-X System, a semi-automated bench-top platform, which incorporates SQI’s technology with the exception of automated fluidics handling. It also provides Ig_plex microarrays that discriminate between individual isotypes of antibodies and antigens, and proteins within a single well of a microarray resulting in the measurement of multiple biomarkers in a single test; and Ig_plex CHEX technology, which offers various in-microarray checks to ensure that the test has been completed without system, control, calibration, or microarray-related errors. The company serves clinical, academic, diagnostic, and pharmaceutical laboratories. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. SQI Diagnostics Inc. is headquartered in Toronto, Canada.

33 Employees
Last Reported Date: 12/17/14

sqi diagnostics inc (SQD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$276.9K
Director of Finance & Administration
Total Annual Compensation: C$115.0K
Vice President of Assay Research & Developmen...
Total Annual Compensation: C$203.1K
Compensation as of Fiscal Year 2014.

sqi diagnostics inc (SQD) Key Developments

SQI Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015

SQI Diagnostics Inc. reported earnings results for the third quarter and nine months ended June 30, 2015. For the quarter, the company generated $180,000 in revenues as compared to $32,000 for the quarter-ended June 30, 2014. Net loss was $1,571,000 or $0.03 net loss per share compared to a net loss of $1,449,000 of $0.03 net loss per share for the quarter-ended June 30, 2014. For the nine months period, the company reported revenue of $265,000 compared to $52,000 for the same period last year. The growth in revenue for the three and nine months ended June 30, 2015, while still modest, reflects development revenue from multiple projects across multiple applications of technology. The loss for the nine months ended June 30, 2015 was $4,549,000 compared to $3,914,000 for the same period last year. The net loss was higher for the three and nine months ended June 30, 2015 as compared to the three and nine months ended June 30, 2014 due to additional expenditures to advance sales and marketing initiatives, increased investor relations and professional fees.

SQI Diagnostics Inc. to Report Q3, 2015 Results on Aug 18, 2015

SQI Diagnostics Inc. announced that they will report Q3, 2015 results at 5:00 PM, Eastern Standard Time on Aug 18, 2015

SQI Diagnostics Inc., Q3 2015 Earnings Call, Aug 19, 2015

SQI Diagnostics Inc., Q3 2015 Earnings Call, Aug 19, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SQD:CN C$0.40 CAD 0.00

SQD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SQD.
View Industry Companies
 

Industry Analysis

SQD

Industry Average

Valuation SQD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 64.3x
Price/Book 29.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 62.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SQI DIAGNOSTICS INC, please visit www.sqidiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.